Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,790 public trials 1,061 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Recruiting

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

NCT06016920

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
Locations
  • Fakultni nemocnice Olomouc, Olomuoc Olomouc, Czechia
  • Hôpital de la Pitié - Salpétrière in Paris Paris, France
  • Hospices Civils De Lyon Lyon, France
  • CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM) Montpellier, France
View all 17 locations
View Trial Details
Recruiting

PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy

NCT05055648

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • Catholic University of Leuven Leuven, Belgium
  • Aarhus University Hospital (AUH) Aarhus, Denmark
  • Centre Léon Bérard (CLB) Lyon, France
  • Centre Antoine Lacassagne (CAL) Nice, France
View all 15 locations
View Trial Details
Recruiting

Chemoradiotherapy in Unresectable Esophageal Cancer

NCT04278287

Conditions
Albumin-bound Paxlitaxel, Chemoradiotherapy, Digestive System Diseases, +10 more
Locations
  • Department 4th of Radiation Oncology, Anyang Cancer Hospital Anyang, Henan, China
  • Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China
  • Department of Radiation oncology, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The affiliated Cancer Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • Department of Radiation oncology, Jiangsu Province Hospital/The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
View Trial Details
Recruiting

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

NCT05668962

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +17 more
Locations
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details

Related conditions